Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1994
Antisense down-regulation of metallothionein in a human monocytic cell line alters adherence, invasion, and the respiratory burstM E Leibbrandt, R Khokha, J KoropatnickOncogene|September 28, 2005
TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesisW Cruz-Muñoz, I Kim, R KhokhaBritish Journal of Cancer|November 13, 2003
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer developmentC V Hojilla, F F Mohammed, R KhokhaJournal of Lipid Research|July 1, 1986
Divergent effects of d-norgestrel on the metabolism of rat very low density and low density apolipoprotein BR Khokha, M W Huff, B M WolfeCancer Metastasis Reviews|June 1, 1995
Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitorsR Khokha, D C Martin, J E FataAnnals of the Rheumatic Diseases|October 9, 2003
Metalloproteinases, inflammation, and rheumatoid arthritisF F Mohammed, D S Smookler, R KhokhaCurrent Molecular Medicine|November 7, 2003
Molecular mechanisms of tumor invasion and metastasis: an integrated viewR A Cairns, R Khokha, R P HillOncogene|October 28, 2014
TIMP3 controls cell fate to confer hepatocellular carcinoma resistanceV Defamie, O Sanchez, A Murthy, et al.Biochimica Et Biophysica Acta|April 3, 1987
Effects of levonorgestrel on enzymes responsible for synthesis of triacylglycerols in rat liverR Khokha, P A Walton, F Possmayer, et al.The Journal of Cell Biology|August 25, 1999
Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1D C Martin, J L Fowlkes, B Babic, et al.Pageof 7